Sign up to save your podcasts
Or
Share Understanding heterogeneity for patient preference data and how it effects the benefit-risk ratio for treatments
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding heterogeneity for patient preference data and how it effects the benefit-risk ratio for treatments
Interview with Marco Boeri
Click here to get to the homepage of the episode!
As
statisticians in the medical field, we’re used to study subgroups of patients
with respect to all kinds of biological variables: from demographics to
genomics. This provides us with a good understanding of how the benefit-risk
profile for a given patient looks like.
However,
the patient might have a completely different view on the importance of the
different benefits and risks. And importantly, these preferences might be less
driven by biologic factors and more by personal experiences and situations as
well as psychological traits. How can we assess patient preferences in this
regard?
Marco
Boeri and I worked on such questions in the past and some work has been presented
at last years PSI conference. In todays episode, we give you some insights into
what’s possible and how you can approach this problem.
View all episodes
By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry
4.4
99 ratings
Interview with Marco Boeri
Click here to get to the homepage of the episode!
As
statisticians in the medical field, we’re used to study subgroups of patients
with respect to all kinds of biological variables: from demographics to
genomics. This provides us with a good understanding of how the benefit-risk
profile for a given patient looks like.
However,
the patient might have a completely different view on the importance of the
different benefits and risks. And importantly, these preferences might be less
driven by biologic factors and more by personal experiences and situations as
well as psychological traits. How can we assess patient preferences in this
regard?
Marco
Boeri and I worked on such questions in the past and some work has been presented
at last years PSI conference. In todays episode, we give you some insights into
what’s possible and how you can approach this problem.
More shows like The Effective Statistician - in association with PSI
View all
Stuff You Should Know
78,438 Listeners
Freakonomics Radio
32,008 Listeners
Planet Money
30,680 Listeners
Hidden Brain
43,548 Listeners
Pivot
9,533 Listeners
JAMA Clinical Reviews
497 Listeners
HBR IdeaCast
164 Listeners
Page 94: The Private Eye Podcast
344 Listeners
The Peter Attia Drive
8,529 Listeners
The Journal.
6,090 Listeners
Huberman Lab
29,186 Listeners
Biotech Hangout
18 Listeners
The Rest Is Politics
3,007 Listeners
DER TRUMP EFFEKT – ZDF auslandsjournal – Der Podcast
18 Listeners
Die Peter Thiel Story
23 Listeners